The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Tumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
Breitman, T. R., Selonick, S. E., & Collins, S. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2936 · Cited by 1,966
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., & Lander, E. S. (2011) · Cell · doi:10.1016/j.cell.2011.07.026 · Cited by 1,475
Homologous recombination in DNA repair and DNA damage tolerance
Li, X., & Heyer, W.-D. (2008) · Cell Research · doi:10.1038/cr.2008.1 · Cited by 1,197
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Sensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,128
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0592 · Cited by 903
Repair of Strand Breaks by Homologous Recombination
Jasin, M., & Rothstein, R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 887
The Role of ABC Transporters in Clinical Practice
Leonard, G. D., Fojo, T., & Bates, S. E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-411 · Cited by 817
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Bleau, A.-M., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C. W., & Holland, E. C. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.007 · Cited by 808
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 780
Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.-J., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192 · Cited by 754
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E., Bentzen, J., Bastholt, L., Hansen, O., Johansen, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14361-9 · Cited by 685
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Liu, W., Laitinen, S., Khan, S., Vihinen, M., Kowalski, J., Yu, G., Chen, L., Ewing, C. M., Eisenberger, M. A., Carducci, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1944 · Cited by 654
Hypoxic Radiosensitization: Adored and Ignored
Overgaard, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7878 · Cited by 619
Chromatin modifiers and remodellers: regulators of cellular differentiation
Chen, T., & Dent, S. Y. R. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3607 · Cited by 619
WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells
Woodward, W. A., Chen, M. S., Behbod, F., Alfaro, M. P., Buchholz, T. A., & Rosen, J. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606599104 · Cited by 603
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
Singh, S., Brocker, C., Koppaka, V., Chen, Y., Jackson, B. C., Matsumoto, A., Thompson, D. C., & Vasiliou, V. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.010 · Cited by 601
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Cheung-Ong, K., Giaever, G., & Nislow, C. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.007 · Cited by 591
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, N. E., Balko, J. M., Dugger, T. C., Kuba, M. G., Sánchez, V., Sanders, M., Stanford, J., Cook, R. S., & Arteaga, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65416 · Cited by 590
Dubrovska, A., Kim, S., Salamone, R. J., Walker, J. R., Maira, S.-M., García-Echeverría, C., Schultz, P. G., & Reddy, V. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810956106 · Cited by 564
Self-citationUnderstanding cancer stem cell heterogeneity and plasticity
Tang, D. G. (2012) · Cell Research · doi:10.1038/cr.2012.13 · Cited by 563
The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
Ma, I., & Allan, A. L. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9208-4 · Cited by 539
Korkaya, H., Kim, G.-I., Davis, A., Malik, F., Henry, N. L., Ithimakin, S., Quraishi, A. A., Tawakkol, N., D'Angelo, R., Paulson, A. K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.014 · Cited by 538
Cancer stem cell niche: the place to be
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3220 · Cited by 518
Fenaux, P., Le Deley, M., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerci, A., Duarte, M., Daniel, M., & Bowen, D. (1993) · Blood · doi:10.1182/blood.v82.11.3241.3241 · Cited by 516
Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
Marcato, P., Dean, C. A., Giacomantonio, C. A., & Lee, P. W. K. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15486 · Cited by 516
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Beà, S., Valdés-Mas, R., Navarro, A., Salaverria, I., Martín-Garcia, D., Jares, P., Giné, E., Pinyol, M., Royo, C., Nadeu, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314608110 · Cited by 513
Chromosomal Instability Confers Intrinsic Multidrug Resistance
Lee, A. J. X., Endesfelder, D., Rowan, A. J., Walther, A., Birkbak, N. J., Futreal, P. A., Downward, J., Szallasi, Z., Tomlinson, I. P. M., Howell, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3604 · Cited by 475
Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells
Notta, F., Mullighan, C. G., Wang, J. C. Y., Poeppl, A., Doulatov, S., Phillips, L. A., Ma, J., Minden, M. D., Downing, J. R., & Dick, J. E. (2011) · Nature · doi:10.1038/nature09733 · Cited by 463
Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70454 · Cited by 457
Chemical Radiosensitizers for Use in Radiotherapy
Wardman, P. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.03.010 · Cited by 447
DNA damage checkpoints in mammals
Niida, H., & Nakanishi, M. (2006) · Mutagenesis · doi:10.1093/mutage/gei063 · Cited by 432
Azab, A. K., Runnels, J. M., Pitsillides, C., Moreau, A.-S., Azab, F., Leleu, X., Jia, X., Wright, R., Ospina, B., Carlson, A. L., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186668 · Cited by 428
Sullivan, J. P., Spinola, M., Dodge, M., Raso, M. G., Behrens, C., Gao, B., Schuster, K., Shao, C., Larsen, J. E., Sullivan, L. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0881 · Cited by 416
van den Hoogen, C., van der Horst, G., Cheung, H., Buijs, J. T., Lippitt, J. M., Guzmán-Ramírez, N., Hamdy, F. C., Eaton, C. L., Thalmann, G. N., Cecchini, M. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3806 · Cited by 398
Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F., & Papaccio, G. (2013) · The FASEB Journal · doi:10.1096/fj.12-218222 · Cited by 395
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
Gong, C., Bauvy, C., Tonelli, G., Yue, W., Deloménie, C., Nicolas, V, Zhu, Y., Domergue, V, Marin-Esteban, V, Tharinger, H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.252 · Cited by 369
Li, T., Su, Y., Mei, Y., Leng, Q., Leng, B., Liu, Z., Stass, S. A., & Jiang, F. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.127 · Cited by 362
Drug Transporters in Drug Efficacy and Toxicity
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134529 · Cited by 359
Thompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357
Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer
Zhang, M., Behbod, F., Atkinson, R. L., Landis, M. D., Kittrell, F., Edwards, D., Medina, D., Tsimelzon, A., Hilsenbeck, S., Green, J. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6353 · Cited by 352
Batchelor, T. T., Gerstner, E. R., Emblem, K. E., Duda, D. G., Kalpathy-Cramer, J., Snuderl, M., Ancukiewicz, M., Polaskova, P., Pinho, M. C., Jennings, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318022110 · Cited by 340
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
Palacios, F., Tushir, J. S., Fujita, Y., & D'Souza-Schorey, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.389-402.2005 · Cited by 333
Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
Golebiewska, A., Brons, N. H. C., Bjerkvig, R., & Niclou, S. P. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.007 · Cited by 333
Touil, Y., Igoudjil, W., Corvaisier, M., Dessein, A.-F., Vandomme, J., Monté, D., Stechly, L., Skrypek, N., Langlois, C., Grard, G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1854 · Cited by 332
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
McAuliffe, S. M., Morgan, S. L., Wyant, G. A., Tran, L. T., Muto, K. W., Chen, Y. S., Chin, K. T., Partridge, J. C., Poole, B. B., Cheng, K.-H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206400109 · Cited by 328
Croker, A. K., & Allan, A. L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1692-y · Cited by 327
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Zannella, V. E., Dal Pra, A., Muaddi, H., McKee, T. D., Stapleton, S., Sykes, J., Glicksman, R., Chaib, S., Zamiara, P., Milosevic, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1787 · Cited by 314
Qiang, L., Wu, T., Zhang, H.-W., Lu, N., Hu, R., Wang, Y.-J., Zhao, L., Chen, F.-H., Wang, X.-T., You, Q.-D., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.95 · Cited by 313
Pathway choice in DNA double strand break repair: observations of a balancing act
Brandsma, I., & Gent, D. C. (2012) · Genome Integrity · doi:10.1186/2041-9414-3-9 · Cited by 308
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
Hu, L., McArthur, C., & Jaffe, R. B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605626 · Cited by 296
Milosevic, M., Warde, P., Ménard, C., Chung, P., Toi, A., Ishkanian, A., McLean, M., Pintilie, M., Sykes, J., Gospodarowicz, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2711 · Cited by 289
Oxidative stress, redox, and the tumor microenvironment
Cook, J. A., Gius, D., Wink, D. A., Krishna, M. C., Russo, A., & Mitchell, J. B. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.001 · Cited by 284
Guan, J.-L., Simon, A. K., Prescott, M., Menendez, J. A., Liu, F., Wang, F., Wang, C., Wolvetang, E., Vazquez-Martin, A., & Zhang, J. (2013) · Autophagy · doi:10.4161/auto.24132 · Cited by 281
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Schott, A. F., Landis, M. D., Dontu, G., Griffith, K. A., Layman, R. M., Krop, I., Paskett, L. A., Wong, H., Dobrolecki, L. E., Lewis, M. T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3326 · Cited by 277
Wei, Y., Jiang, Y., Zou, F., Liu, Y., Wang, S., Xu, N., Xu, W., Cui, C., Xing, Y., Liu, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217002110 · Cited by 274
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Yang, X., Zhang, X., Fu, M. L., Weichselbaum, R. R., Gajewski, T. F., Guo, Y., & Fu, Y.-X. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.004 · Cited by 269
Galavotti, S., Bartesaghi, S., Faccenda, D., Shaked-Rabi, M., Sanzone, S., McEvoy, A., Dinsdale, D., Condorelli, F., Brandner, S., Campanella, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.111 · Cited by 266
Adhikari, A. S., Agarwal, N., Wood, B. M., Porretta, C., Ruiz, B., Pochampally, R. R., & Iwakuma, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3463 · Cited by 261
ARCON: a novel biology-based approach in radiotherapy
Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 256
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Dubrovska, A., Cojoc, M., Peitzsch, Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 254
Self-citationFacchino, S., Abdouh, M., Chatoo, W., & Bernier, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1634-10.2010 · Cited by 253
Double strand break repair functions of histone H2AX
Scully, R., & Xie, A. (2013) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2013.07.007 · Cited by 252
Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer
Magni, M., Shammah, S., Schiro, R., Mellado, W., Dalla-Favera, R., & Gianni, A. (1996) · Blood · doi:10.1182/blood.v87.3.1097.bloodjournal8731097 · Cited by 251
Hwang-Verslues, W. W., Kuo, W.-H., Chang, P.-H., Pan, C.-C., Wang, H.-H., Tsai, S.-T., Jeng, Y.-M., Shew, J.-Y., Kung, J. T., Chen, C.-H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008377 · Cited by 223
Human ABCG2: structure, function, and its role in multidrug resistance.
Mo, W., & Zhang, J. (2012) · PubMed Central · Cited by 218
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
Liu, P.-P., Liao, J., Tang, Z.-J., Wu, W.-J., Yang, J., Zeng, Z.-L., Hu, Y., Wang, P., Ju, H.-Q., Xu, R.-H., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.131 · Cited by 218
Nguyen, H. G., Yang, J. C., Kung, H.-J., Shi, X.-B., Tilki, D., Lara, P. N., DeVere White, R. W., Gao, A. C., & Evans, C. P. (2014) · Oncogene · doi:10.1038/onc.2014.25 · Cited by 212
Wang, W.-J., Wu, S.-P., Liu, J.-B., Shi, Y.-S., Huang, X., Zhang, Q.-B., & Yao, K.-T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1408 · Cited by 212
Liu, Y.-P., Yang, C.-J., Huang, M.-S., Yeh, C.-T., Wu, A. T. H., Lee, Y.-C., Lai, T.-C., Lee, C.-H., Hsiao, Y.-W., Lu, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1733 · Cited by 210
Molecular Pharmacology of ABCG2 and Its Role in Chemoresistance
Stacy, A. E., Jansson, P. J., & Richardson, D. R. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088609 · Cited by 210
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications
Tegeder, I., & Geisslinger, G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.2 · Cited by 204
Ulasov, I. V., Nandi, S., Dey, M., Sonabend, A. M., & Lesniak, M. S. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00062 · Cited by 204
Future medical applications of single-cell sequencing in cancer
Navin, N., & Hicks, J. (2011) · Genome Medicine · doi:10.1186/gm247 · Cited by 199
Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures
Ropolo, M., Daga, A., Griffero, F., Foresta, M., Casartelli, G., Zunino, A., Poggi, A., Cappelli, E., Zona, G., Spaziante, R., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0409 · Cited by 198
Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis
Sofia Vala, I., Martins, L. R., Imaizumi, N., Nunes, R. J., Rino, J., Kuonen, F., Carvalho, L. M., Rüegg, C., Grillo, I. M., Barata, J. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011222 · Cited by 194
Singh, A., Wu, H., Zhang, P., Happel, C., Ma, J., & Biswal, S. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0108 · Cited by 192
Xie, M., Zhang, L., He, C., Xu, F., Liu, J., Hu, Z., Zhao, L., & Tian, Y. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24019 · Cited by 191
Developmental signaling pathways in cancer stem cells of solid tumors
Karamboulas, C., & Ailles, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.008 · Cited by 190
Discovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz-Schughart, L., Baumann, M., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 189
Self-citationCD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
de Jong, M. C., Pramana, J., van der Wal, J. E., Lacko, M., Peutz-Kootstra, C. J., de Jong, J. M., Takes, R. P., Kaanders, J. H., van der Laan, B. F., Wachters, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0799 · Cited by 185
Zeng, Z., Samudio, I. J., Munsell, M., An, J., Huang, Z., Estey, E., Andreeff, M., & Konopleva, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0228 · Cited by 184
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
Bartucci, M., Svensson, S., Romania, P., Dattilo, R., Patrizii, M., Signore, M., Navarra, S., Lotti, F., Biffoni, M., Pilozzi, E., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.170 · Cited by 181
Bao, B., Ali, S., Ahmad, A., Azmi, A. S., Li, Y., Banerjee, S., Kong, D., Sethi, S., Aboukameel, A., Padhye, S. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050165 · Cited by 178
Kong, Y., Yoshida, S., Saito, Y., Doi, T., Nagatoshi, Y., Fukata, M., Saito, N., Yang, S. M., Iwamoto, C., Okamura, J., et al. (2008) · Leukemia · doi:10.1038/leu.2008.83 · Cited by 169
Chiarini, F., Grimaldi, C., Ricci, F., Tazzari, P. L., Evangelisti, C., Ognibene, A., Battistelli, M., Falcieri, E., Melchionda, F., Pession, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1814 · Cited by 166
GABA’s Control of Stem and Cancer Cell Proliferation in Adult Neural and Peripheral Niches
Young, S. Z., & Bordey, A. (2009) · Physiology · doi:10.1152/physiol.00002.2009 · Cited by 165
Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., Kong, Y., Brown, M. L., Toretsky, J. A., & Loeb, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013943 · Cited by 163
ABCG2: the key to chemoresistance in cancer stem cells?
An, Y., & Ongkeko, W. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903228834 · Cited by 162
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Rasper, M., Schafer, A., Piontek, G., Teufel, J., Brockhoff, G., Ringel, F., Heindl, S., Zimmer, C., & Schlegel, J. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq070 · Cited by 158
Moreb, J. S., Baker, H. V., Chang, L., et al. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-87 · Cited by 157
Chikazawa, N., Tanaka, H., Tasaka, T., Nakamura, M., Tanaka, M., Onishi, H., & Katano, M. (2010) · PubMed · Cited by 147
Epigenetic Regulation of SOX9 by the NF-κB Signaling Pathway in Pancreatic Cancer Stem Cells
Sun, L., Mathews, L., Cabarcas‐Petroski, S., Zhang, X., Yang, A., Zhang, Y., Young, M. R., Klarmann, K. D., Keller, J. R., & Farrar, W. L. (2013) · Stem Cells · doi:10.1002/stem.1394 · Cited by 143
Functional relevance of the histone γH2Ax in the response to DNA damaging agents
Revet, I. M., Feeney, L., Bruguera, S., Wilson, W., Dong, T. K., Oh, D. H., Dankort, D. L., & Cleaver, J. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105866108 · Cited by 142
The hypoxia factor Hif-1α controls neural crest chemotaxis and epithelial to mesenchymal transition
Barriga, E. H., Maxwell, P. H., Reyes, A. E., & Mayor, R. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201212100 · Cited by 140
Cancer biomarker discovery: Current status and future perspectives
Mäbert, K., Cojoc, M., Peitzsch, C., Kurth, I., Souchelnytskyi, S., & Dubrovska, A. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892229 · Cited by 139
Self-citationYin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 135
CXCR4 Expression in Prostate Cancer Progenitor Cells
Dubrovska, A., Elliott, J., Salamone, R. J., Телегеев, Г. Д., Stakhovskyi, A. E., Schepotin, I. B., Yan, F., Wang, Y., Bouchez, L. C., Kularatne, S. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031226 · Cited by 134
Self-citationDrug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Wang, Y.-C., Chao, T., Chang, C., Yo, Y.-T., Yu, M.-H., & Lai, H.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074538 · Cited by 132
Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment
Rausch, V., Liu, L., Apel, A., Rettig, T., Gladkich, J., Labsch, S., Kallifatidis, G., Kaczorowski, A., Groth, A., Groß, W., et al. (2012) · The Journal of Pathology · doi:10.1002/path.3994 · Cited by 131
Koukourakis, M. I., Giatromanolaki, A. N., Tsakmaki, V., Danielidis, V., & Sivridis, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.33 · Cited by 130
What makes cancer stem cell markers different?
Karsten, U. R., & Goletz, S. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-301 · Cited by 130
Fischer, M. M., Yen, W.-C., Kapoun, A. M., Wang, M., O’Young, G., Lewicki, J. A., Gurney, A. L., & Hoey, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2817 · Cited by 124
Desai, A. B., Webb, B. M., & Gerson, S. L. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.10.040 · Cited by 122
Hypoxic tumor cell radiosensitization through nitric oxide
Ridder, M. D., Verellen, D., Verovski, V. N., & Storme, G. A. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.015 · Cited by 116
Targeting Head and Neck Cancer Stem Cells to Overcome Resistance to Photon and Carbon Ion Radiation
Bertrand, G., Maalouf, M., Boivin, A., Battiston-Montagne, P., Beuve, M., Lévy, A., Jalade, P., Fournier, C., Ardail, D., Magné, N., et al. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9467-y · Cited by 116
Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy
Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., KANO, Y., Ohta, K., Fukusumi, T., Sakai, D., Kudo, T., Haraguchi, N., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1837 · Cited by 114
Rao, R., Balusu, R., Fiskus, W. C., Mudunuru, U., Venkannagari, S., Chauhan, L., Smith, J. E., Hembruff, S. L., Ha, K., Atadja, P. W., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0979 · Cited by 112
Gallmeier, E., Hermann, P. C., Mueller, M.-T., Machado, J. G., Ziesch, A., Toni, E. N. D., Palagyi, A., Eisen, C., Ellwart, J. W., Rivera, J., et al. (2011) · Stem Cells · doi:10.1002/stem.595 · Cited by 106
Ajani, J. A., Wang, X., Song, S., Suzuki, A., Taketa, T., Sudo, K., Wadhwa, R., Hofstetter, W. L., Komaki, R. U., Maru, D. M., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.10.007 · Cited by 105
Nakanishi, T., Chumsri, S., Khakpour, N., Brodie, A., Leyland-Jones, B., Hamburger, A. W., Ross, D. D., & Burger, A. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605553 · Cited by 104
Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma
Schäfer, A., Teufel, J., Ringel, F. A., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos270 · Cited by 102
Lundholm, L., Hååg, P., Zong, D., Juntti, T., Mörk, B., Lewensohn, R., & Viktorsson, K. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.211 · Cited by 101
Siemens, D. R., Heaton, J. P. W., Adams, M. A., Kawakami, J., & Graham, C. H. (2009) · Urology · doi:10.1016/j.urology.2009.03.004 · Cited by 100
Hypoxia induces a hedgehog response mediated by HIF‐1α
Bijlsma, M. F., Groot, A. P., Oduro, J. P., Franken, R. J., Schoenmakers, S. H. H. F., Peppelenbosch, M. P., & Spek, C. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00491.x · Cited by 100
Cho, K. H., Choi, M., Jeong, K. J., Kim, J. J., Hwang, M. H., Shin, S. C., Park, C. G., & Lee, H. Y. (2014) · The Prostate · doi:10.1002/pros.22776 · Cited by 98
The properties of a mammary gland cancer stem cell
Zucchi, I., Sanzone, S., Astigiano, S., Pelucchi, P., Scotti, M. A., Valsecchi, V., Barbieri, O., Bertoli, G. R., Albertini, A., Reinbold, R. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703071104 · Cited by 98
How to manage acute promyelocytic leukemia
Mi, J.-Q., Li, J., Shen, Z.-X., Chen, S.-J., & Chen, Z. (2012) · Leukemia · doi:10.1038/leu.2012.57 · Cited by 97
Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.127 · Cited by 97
Chung, Y., Jian, J. J., Cheng, S. H., Tsai, S. Y., Chuang, V. P., Soong, T. C., Lin, Y., & Horng, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2721 · Cited by 97
Liu, J., Xiao, Z., Wong, S. K., Tin, V. P., Ho, K.-Y., Wang, J., Sham, M. H., & Wong, M. P. (2013) · Oncotarget · doi:10.18632/oncotarget.1246 · Cited by 95
Studies on the Radiosensitizing Effect of Oxygen in Chinese Hamster Cells
Chapman, J. D., Dugle, D. L., Reuvers, A. P., Meeker, B. E., & Borsa, J. (1974) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007414551361 · Cited by 95
Moreb, J. S., Gabr, A., Vartikar, G. R., Gowda, S., Zucali, J. R., & Mohuczy, D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072496 · Cited by 93
Armstrong, A. B., Wang, M., Eble, J. N., MacLennan, G. T., Montironi, R., Tan, P., Antonio Lopez-beltran, B., Zhang, S., Baldridge, L. A., Spartz, H., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.176 · Cited by 89
Kuonen, F., Secondini, C., & Rüegg, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1758 · Cited by 89
Autophagy Control by the VEGF-C/NRP-2 Axis in Cancer and Its Implication for Treatment Resistance
Stanton, M. J., Dutta, S., Zhang, H., Polavaram, N. S., Leontovich, A. A., Hönscheid, P., Sinicrope, F. A., Tindall, D. J., Muders, M. H., & Datta, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3635 · Cited by 86
Self-citationChua, C. L., Zaiden, N., Chong, K.-H., See, S.-J., Wong, M. C., Ang, B.-T., & Tang, C. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/11/0856 · Cited by 85
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
Pecqueur, C., Oliver, L., Oizel, K., Lalier-Bretaudeau, L., & Vallette, F. M. (2013) · International Journal of Cell Biology · doi:10.1155/2013/805975 · Cited by 84
Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
Magnen, C. L., Bubendorf, L., Rentsch, C. A., Mengus, C., Gsponer, J. R., Zellweger, T., Rieken, M., Thalmann, G. N., Cecchini, M. G., Germann, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2857 · Cited by 82
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.
Cillo, C., Dick, J. E., Ling, V., & Hill, R. P. (1987) · PubMed · Cited by 81
Mu, X., Isaac, C. E., Greco, N., Huard, J., & Weiss, K. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00143 · Cited by 81
Targeting survival pathways in chronic myeloid leukaemia stem cells
Sinclair, A., Latif, A. L., & Holyoake, T. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12183 · Cited by 80
Corominas-Faja, B., Oliveras‐Ferraros, C., Cuyàs, E., Segura‐Carretero, A., Joven, J., Martín-Castillo, B., Barrajón‐Catalán, E., Micol, V., Bosch‐Barrera, J., & Menéndez, J. A. (2013) · Cell Cycle · doi:10.4161/cc.26417 · Cited by 80
BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
Huang, W., Hsieh, Y.-L., Hung, C., Chien, P., Chien, Y.-F., Chen, L.-C., Tu, C., Chen, C., Hsu, S.-C., Lin, Y.-M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083627 · Cited by 79
HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0505 · Cited by 79
The Tumor Microenvironment: A Target for Combination therapy of Breast Cancer
Reisfeld, R. A. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.70 · Cited by 78
Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer
Ji, C., Zhang, L., Cheng, Y., Patel, R., Wu, H., Zhang, Y., Wang, M., Ji, S., Belani, C. P., Yang, J., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28162 · Cited by 77
Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro
Mihatsch, J., Toulany, M., Bareiss, P. M., Grimm, S., Lengerke, C., Kehlbach, R., & Rodemann, H. P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.003 · Cited by 73
Yasuda, K., Torigoe, T., Morita, R., Kuroda, T., Takahashi, A., Matsuzaki, J., Kochin, V., Asanuma, H., Hasegawa, T., Saito, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068187 · Cited by 73
Katayama, R., Koike, S., Sato, S., Sugimoto, Y., Tsuruo, T., & Fujita, N. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01288.x · Cited by 73
Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers
Smit, J. K., Faber, H., Niemantsverdriet, M., Baanstra, M., Bussink, J., Hollema, H., van Os, R. P., Plukker, J. T. M., & Coppes, R. P. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.03.027 · Cited by 69
Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor
Hämmerle, B., Yáñez, Y., Palanca, S., Cañete, A., Burks, D. J., Castel, V., & de Mora, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076761 · Cited by 68
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
den broeck, A. V., Gremeaux, L., Topal, B., & Vankelecom, H. E. J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-354 · Cited by 67
Chk1 knockdown confers radiosensitization in prostate cancer stem cells
WANG, X., Ma, Z., XIAO, Z., Liu, H., Dou, Z., Feng, X., & Shi, H. (2012) · Oncology Reports · doi:10.3892/or.2012.2068 · Cited by 66
Hou, H., Sun, H., Lü, P., Ge, C., Zhang, L., Li, H., Zhao, F., Tian, H., Zhang, L., Chen, T., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0201 · Cited by 65
Autophagy and Cellular Senescence Mediated by Sox2 Suppress Malignancy of Cancer Cells
Cho, Y., Kim, D. J., Lee, H. S., Jeong, C. H., Cho, E.-J., Kim, M.-O., Byun, S., Lee, K. Y., Yao, K., Carper, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057172 · Cited by 64
Kim, S. K., Kim, H., Lee, D.-H., Kim, T., Kim, T., Chung, C., Koh, G. Y., Kim, H., & Lim, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078130 · Cited by 63
Elzinga, B. M., Nyhan, M. J., Crowley, L. C., O’Donovan, T. R., Cahill, M. R., & McKenna, S. L. (2013) · American Journal of Hematology · doi:10.1002/ajh.23428 · Cited by 61
Yashiro, M., Nishii, T., Hasegawa, T., Matsuzaki, T., Morisaki, T., Fukuoka, T., & Hirakawa, K. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.638 · Cited by 58
Zhang, G., Wang, Z., Luo, W., Jiao, H., Wu, J., & Jiang, C. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/782581 · Cited by 58
Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells
Chen, Y., Li, D., Wang, D., Liu, X., Yin, N. B., Song, Y., Lu, S., Ju, Z., & Zhan, Q. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24228 · Cited by 56
Potiron, V. A., Abderrhamani, R., Giang, E., Chiavassa, S., di Tomaso, E., Maira, S.-M., Paris, F., & Supiot, S. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.11.014 · Cited by 56
Huang, F.-F., Wu, D., Zhang, L., Yu, Y., Yuan, X., Li, W., Chen, X., Zhao, X., Chen, F., & Zeng, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.006 · Cited by 55
Mu, X., Isaac, C. E., Schott, T., Huard, J., & Weiss, K. R. (2013) · Sarcoma · doi:10.1155/2013/480713 · Cited by 53
Wouters, J., Stas, M., Gremeaux, L., Govaere, O., den broeck, A. V., Maes, H., Agostinis, P., Roskams, T., van den Oord, J. J., & Vankelecom, H. E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076550 · Cited by 52
Grunt, T., Dittrich, E., Offterdinger, M., Schneider, S., Dittrich, C., & Huber, H. P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.446 · Cited by 51
Zhao, Y., Bao, Q., Schwarz, B., Zhao, L., Mysliwietz, J., Ellwart, J. W., Renner, A., Hirner, H., Nieß, H., Čamaj, P., et al. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0103 · Cited by 49
miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype
Wang, H., Guo, Y., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., & Luo, H. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24574 · Cited by 47
Wang, X., Liu, Q., Hou, B., Zhang, W., Yan, M., Jia, H., Li, H., Yan, D., Zheng, F.-M., Ding, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073942 · Cited by 45
Cancer Stem Cell Targeting: the Next Generation of Cancer Therapy and Molecular Imaging
Shigdar, S. L., Lin, J., Li, Y., Yang, C. J., Wei, M., Zhu, Y., Liu, H., & Duan, W. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.148 · Cited by 44
Cancer Stem Cell-Like Side Population Cells in Clear Cell Renal Cell Carcinoma Cell Line 769P
Huang, B., Huang, Y., Yao, Z. J., Chen, X., Guo, S. J., Mao, X., Wang, D. H., Chen, J. X., & Qiu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068293 · Cited by 44
D’Addario, C., Johansson, S., Candeletti, S., Romualdi, P., Ögren, S. O., Terenius, L. Y., & Ekström, T. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-168534 · Cited by 42
Zhang, S., Huang, F., Huang, Y., Zhong, W., & Yu, Z. (2010) · Tumori Journal · doi:10.1177/548.6520 · Cited by 36
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G 2 fraction
Al‐Assar, O., Mantoni, T. S., Lunardi, S., Kingham, G. L., Helleday, T., & Brunner, T. B. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15699 · Cited by 35
Kim, S.-Y., Rhee, J. G., Song, X., Prochownik, E. V., Spitz, D. R., & Lee, Y. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050423 · Cited by 31
ABCG2: Recent Discovery of Potent and Highly Selective Inhibitors
Lecerf-Schmidt, F., Pérès, B., Valdameri, G., Gauthier, C., Winter, E., Payen, L. F., Pietro, A. D., & Boumendjel, A. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.71 · Cited by 29
Novel radiosensitizing anticancer therapeutics.
Linkous, A. G., & Yazlovitskaya, E. M. (2012) · PubMed · Cited by 28
Sobhan, P. K., Seervi, M., Joseph, J., Chandrika, B. B., Varghese, S., Santhoshkumar, T. R., & Pillai, M. R. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.009 · Cited by 15
The Role of Cancer Stem Cells in Tumor Radioresistance
Kurth, I., Peitzsch, C., Baumann, M. A., & Dubrovska, A. (2014) · Wiley eBooks · doi:10.1002/9781118356203.ch35 · Cited by 7
Self-citationCharacterization and Clinical Relevance of ALDH bright Populations in Prostate Cancer
Bubendorf, L., Rentsch, C. A., Mengus, C., et al. (2013) · Cited by 6
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869
Lee, S. Y., Jeong, E. K., Ju, M. K., Jeon, H. M., Kim, M. Y., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0577-4 · Cited by 578
HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Balamurugan, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.29519 · Cited by 572
Metadata
- Authors
- Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 31
- Pages
- 16-27
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2023529679
- Cited by
- 393
- References
- 198
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.